Characteristics of long-COVID among older adults: a cross-sectional study

Int J Infect Dis. 2022 Dec:125:287-293. doi: 10.1016/j.ijid.2022.09.035. Epub 2022 Oct 1.

Abstract

Objectives: To describe long-COVID symptoms among older adults and to assess the risk factors for two common long-COVID symptoms: fatigue and dyspnea.

Methods: This is a multicenter, prospective cohort study conducted in Israel, Switzerland, Spain, and Italy. Individuals were included at least 30 days after their COVID-19 diagnosis. We compared long-COVID symptoms between elderly (aged >65 years) and younger individuals (aged 18-65 years) and conducted univariate and multivariable analyses for the predictors of long-COVID fatigue and dyspnea.

Results: A total of 2333 individuals were evaluated at an average of 5 months (146 days [95% confidence interval 142-150]) after COVID-19 onset. The mean age was 51 years, and 20.5% were aged >65 years. Older adults were more likely to be symptomatic, with the most common symptoms being fatigue (38%) and dyspnea (30%); they were more likely to complain of cough and arthralgia and have abnormal chest imaging and pulmonary function tests. Independent risk factors for long-COVID fatigue and dyspnea included female gender, obesity, and closer proximity to COVID-19 diagnosis; older age was not an independent predictor.

Conclusion: Older individuals with long-COVID have different persisting symptoms, with more pronounced pulmonary impairment. Women and individuals with obesity are at risk. Further research is warranted to investigate the natural history of long-COVID among the elderly population and to assess possible interventions aimed at promoting rehabilitation and well-being.

Keywords: COVID-19; Long-COVID; Long-lasting symptoms; Older adults; Post-COVID-19; SARS-CoV-2.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • COVID-19 Testing
  • COVID-19* / epidemiology
  • Cross-Sectional Studies
  • Dyspnea / etiology
  • Fatigue / etiology
  • Female
  • Humans
  • Middle Aged
  • Obesity
  • Post-Acute COVID-19 Syndrome*
  • Prospective Studies